These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 22686467

  • 1. Elevated soluble HLA II protein levels in patients with alpha-1 antitrypsin deficiency with or without COPD.
    Li L, Kueppers F, Hildebrand W, Buchli R, Gaughan J.
    Exp Lung Res; 2012 Aug; 38(6):302-6. PubMed ID: 22686467
    [Abstract] [Full Text] [Related]

  • 2. Alpha-1 antitrypsin is elevated in exhaled breath condensate and serum in exacerbated COPD patients.
    Koczulla AR, Noeske S, Herr C, Koepke J, Jörres RA, Nell C, Schmid S, Vogelmeier C, Bals R.
    Respir Med; 2012 Jan; 106(1):120-6. PubMed ID: 21872457
    [Abstract] [Full Text] [Related]

  • 3. Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD.
    Sinden NJ, Stockley RA.
    Eur Respir J; 2013 May; 41(5):1042-50. PubMed ID: 22936713
    [Abstract] [Full Text] [Related]

  • 4. Exhaled nitric oxide levels in alpha-1-antitrypsin PiMZ subjects.
    Malerba M, Ragnoli B, Radaeli A.
    J Intern Med; 2009 Mar; 265(3):382-7. PubMed ID: 19019191
    [Abstract] [Full Text] [Related]

  • 5. Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.
    Janciauskiene S, Welte T.
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S280-8. PubMed ID: 27564662
    [Abstract] [Full Text] [Related]

  • 6. Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.
    Hollander C, Westin U, Wallmark A, Piitulainen E, Sveger T, Janciauskiene SM.
    BMC Pulm Med; 2007 Jan 29; 7():1. PubMed ID: 17261175
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
    Adamashvili I, Pressly T, Gebel H, Milford E, Wolf R, Mancini M, Sittg K, Ghali GE, Hall V, McDonald JC.
    Rheumatol Int; 2002 Jun 29; 22(2):71-6. PubMed ID: 12070679
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The ability of serum from alpha 1-antitrypsin-deficient patients to inhibit PRT-201, a recombinant human type I pancreatic elastase.
    Qamar AA, Burke SK, Lafleur JD, Ding BC, Bland KS, Wong MD, Gustafson PN, Blair AT, Franano FN.
    Biotechnol Appl Biochem; 2012 Jun 29; 59(1):22-8. PubMed ID: 22332741
    [Abstract] [Full Text] [Related]

  • 12. Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases.
    Topic A, Stankovic M, Divac-Rankov A, Petrovic-Stanojevic N, Mitic-Milikic M, Nagorni-Obradovic L, Radojkovic D.
    Genet Test Mol Biomarkers; 2012 Nov 29; 16(11):1282-6. PubMed ID: 22971141
    [Abstract] [Full Text] [Related]

  • 13. Different Training-Induced Skeletal Muscle Adaptations in COPD Patients with and without Alpha-1 Antitrypsin Deficiency.
    Jarosch I, Gehlert S, Jacko D, Koczulla RA, Wencker M, Welte T, Bloch W, Janciauskiene S, Kenn K.
    Respiration; 2016 Nov 29; 92(5):339-347. PubMed ID: 27686000
    [Abstract] [Full Text] [Related]

  • 14. Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro.
    Geraghty P, Rogan MP, Greene CM, Brantly ML, O'Neill SJ, Taggart CC, McElvaney NG.
    Thorax; 2008 Jul 29; 63(7):621-6. PubMed ID: 18250185
    [Abstract] [Full Text] [Related]

  • 15. Variability of sputum inflammatory mediators in COPD and α1-antitrypsin deficiency.
    Stone H, McNab G, Wood AM, Stockley RA, Sapey E.
    Eur Respir J; 2012 Sep 29; 40(3):561-9. PubMed ID: 22700846
    [Abstract] [Full Text] [Related]

  • 16. Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection.
    Weng PJ, Fu YM, Ding SX, Xu DP, Lin A, Yan WH.
    Hum Immunol; 2011 May 29; 72(5):406-11. PubMed ID: 21377504
    [Abstract] [Full Text] [Related]

  • 17. Effect of expectoration on inflammation in induced sputum in alpha-1-antitrypsin deficiency.
    Gompertz S, Hill AT, Bayley DL, Stockley RA.
    Respir Med; 2006 Jun 29; 100(6):1094-9. PubMed ID: 16257194
    [Abstract] [Full Text] [Related]

  • 18. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
    Rizzo R, Andersen AS, Lassen MR, Sørensen HC, Bergholt T, Larsen MH, Melchiorri L, Stignani M, Baricordi OR, Hviid TV.
    Am J Reprod Immunol; 2009 Nov 29; 62(5):320-38. PubMed ID: 19811467
    [Abstract] [Full Text] [Related]

  • 19. Free light chains: potential biomarker and predictor of mortality in alpha-1-antitrypsin deficiency and usual COPD.
    Hampson JA, Stockley RA, Turner AM.
    Respir Res; 2016 Mar 31; 17():34. PubMed ID: 27036487
    [Abstract] [Full Text] [Related]

  • 20. [The investigation of genotype and expression of alpha1-AT in patients with COPD].
    Zhang Y, He B, Zhao MW, Wang XH, Jiang L, Yao WZ.
    Zhonghua Yi Xue Za Zhi; 2005 May 18; 85(18):1270-3. PubMed ID: 16029614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.